Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Research article

Changes of predominant species/biovars and sequence types of Brucellaisolates, Inner Mongolia, China

Authors: Yanfen Chen, Yuehua Ke, Yufei Wang, Xitong Yuan, Xiaoyan Zhou, Hai Jiang, Zhoujia Wang, Qing Zhen, Yaqin Yu, Liuyu Huang, Buyun Cui, Zeliang Chen

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

Human brucellosis incidence in China was divided into 3 stages, high incidence (1950-1960s), decline (1970-1980s) and re-emergence (1990-2000s). Human brucellosis has been reported in all the 32 provinces, of which Inner Mongolia has the highest prevalence, accounting for over 40% of the cases in China. To investigate the etiology alteration of human brucellosis in Inner Mongolia, the species, biovars and genotypes of 60 Brucella isolates from this province were analyzed.

Methods

Species and biovars of the Brucella strains isolated from outbreaks were determined based on classical identification procedures. Strains were genotyped by multi locus sequence typing (MLST). Sequences of 9 housekeeping genes were obtained and sequence types were defined. The distribution of species, biovars and sequence types (STs) among the three incidence stages were analyzed and compared.

Results

The three stages of high incidence, decline and re-emergence were predominated by B. melitensis biovar 2 and 3, B. abortus biovar 3, and B. melitensis biovar 1, respectively, implying changes in the predominant biovars. Genotyping by MLST revealed a total of 14 STs. Nine STs (from ST28 to ST36), accounting for 64.3% of all the STs, were newly defined and different from those observed in other countries. Different STs were distributed among the three stages. ST8 was the most common ST in 1950-1960s and 1990-2000s, while ST2 was the most common in 1970-1980s.

Conclusions

The prevalence of biovars and sequence types of Brucella strains from Inner Mongolia has changed over time in the three stages. Compared with those from other countries, new sequence types of Brucella strains exist in China.
Appendix
Available only for authorised users
Literature
1.
go back to reference Verger J, Grimont F, Grimont P, Grayon M: Brucella, a monospecific genus as shown by deoxyribonucleic acid hybridization. Int J Syst Evol Microbiol. 1985, 35 (3): 292- Verger J, Grimont F, Grimont P, Grayon M: Brucella, a monospecific genus as shown by deoxyribonucleic acid hybridization. Int J Syst Evol Microbiol. 1985, 35 (3): 292-
2.
go back to reference Moreno E, Cloeckaert A, Moriyon I: Brucella evolution and taxonomy. Vet Microbiol. 2002, 90 (1–4): 209-227.CrossRefPubMed Moreno E, Cloeckaert A, Moriyon I: Brucella evolution and taxonomy. Vet Microbiol. 2002, 90 (1–4): 209-227.CrossRefPubMed
3.
go back to reference Zia SH, Wang FL: Brucellosis in north China; a clinical, etiological and epidemiological study. Am J Trop Med Hyg. 1949, 29 (6): 925-936.PubMed Zia SH, Wang FL: Brucellosis in north China; a clinical, etiological and epidemiological study. Am J Trop Med Hyg. 1949, 29 (6): 925-936.PubMed
4.
go back to reference Deqiu S, Donglou X, Jiming Y: Epidemiology and control of brucellosis in China. Vet Microbiol. 2002, 90 (1–4): 165-182.CrossRefPubMed Deqiu S, Donglou X, Jiming Y: Epidemiology and control of brucellosis in China. Vet Microbiol. 2002, 90 (1–4): 165-182.CrossRefPubMed
5.
go back to reference Zhang WY, Guo WD, Sun SH, Jiang JF, Sun HL, Li SL, Liu W, Cao WC: Human brucellosis, Inner Mongolia, China. Emerg Infect Dis. 2010, 16 (12): 2001-2003. 10.3201/eid1612.091081.CrossRefPubMedPubMedCentral Zhang WY, Guo WD, Sun SH, Jiang JF, Sun HL, Li SL, Liu W, Cao WC: Human brucellosis, Inner Mongolia, China. Emerg Infect Dis. 2010, 16 (12): 2001-2003. 10.3201/eid1612.091081.CrossRefPubMedPubMedCentral
6.
go back to reference Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, Zhang Q, Zhou J, Zurth K, Caugant DA, et al: Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A. 1998, 95 (6): 3140-3145. 10.1073/pnas.95.6.3140.CrossRefPubMedPubMedCentral Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, Zhang Q, Zhou J, Zurth K, Caugant DA, et al: Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A. 1998, 95 (6): 3140-3145. 10.1073/pnas.95.6.3140.CrossRefPubMedPubMedCentral
8.
go back to reference Whatmore AM, Perrett LL, MacMillan AP: Characterisation of the genetic diversity of Brucella by multilocus sequencing. BMC Microbiol. 2007, 7: 34-10.1186/1471-2180-7-34.CrossRefPubMedPubMedCentral Whatmore AM, Perrett LL, MacMillan AP: Characterisation of the genetic diversity of Brucella by multilocus sequencing. BMC Microbiol. 2007, 7: 34-10.1186/1471-2180-7-34.CrossRefPubMedPubMedCentral
9.
go back to reference Chen Y, Zhen Q, Wang Y, Xu J, Sun Y, Li T, Gao L, Guo F, Wang D, Yuan X, et al: Development of an extended multilocus sequence typing for genotyping of Brucella isolates. J Microbiol Methods. 2011, 86 (2): 252-254. 10.1016/j.mimet.2011.05.013.CrossRefPubMed Chen Y, Zhen Q, Wang Y, Xu J, Sun Y, Li T, Gao L, Guo F, Wang D, Yuan X, et al: Development of an extended multilocus sequence typing for genotyping of Brucella isolates. J Microbiol Methods. 2011, 86 (2): 252-254. 10.1016/j.mimet.2011.05.013.CrossRefPubMed
10.
go back to reference Burland TG: DNASTAR’s Lasergene sequence analysis software. Methods Mol Biol. 2000, 132: 71-91.PubMed Burland TG: DNASTAR’s Lasergene sequence analysis software. Methods Mol Biol. 2000, 132: 71-91.PubMed
11.
go back to reference Jolley K, Feil E, Chan MS, Maiden MCJ: Sequence type analysis and recombinational tests (START). Bioinformatics. 2001, 17 (12): 1230-10.1093/bioinformatics/17.12.1230.CrossRefPubMed Jolley K, Feil E, Chan MS, Maiden MCJ: Sequence type analysis and recombinational tests (START). Bioinformatics. 2001, 17 (12): 1230-10.1093/bioinformatics/17.12.1230.CrossRefPubMed
12.
go back to reference Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S: MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011, 28 (10): 2731-2739. 10.1093/molbev/msr121.CrossRefPubMedPubMedCentral Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S: MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011, 28 (10): 2731-2739. 10.1093/molbev/msr121.CrossRefPubMedPubMedCentral
13.
go back to reference Saitou N, Nei M: The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987, 4 (4): 406-PubMed Saitou N, Nei M: The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987, 4 (4): 406-PubMed
14.
go back to reference Felsenstein J: Confidence limits on phylogenies: an approach using the bootstrap. Evolution. 1985, 39 (4): 783-791. 10.2307/2408678.CrossRef Felsenstein J: Confidence limits on phylogenies: an approach using the bootstrap. Evolution. 1985, 39 (4): 783-791. 10.2307/2408678.CrossRef
15.
go back to reference Bandelt HJ, Dress AW: Split decomposition: a new and useful approach to phylogenetic analysis of distance data. Mol Phylogenet Evol. 1992, 1 (3): 242-252. 10.1016/1055-7903(92)90021-8.CrossRefPubMed Bandelt HJ, Dress AW: Split decomposition: a new and useful approach to phylogenetic analysis of distance data. Mol Phylogenet Evol. 1992, 1 (3): 242-252. 10.1016/1055-7903(92)90021-8.CrossRefPubMed
16.
go back to reference Boone H: Malta fever in China. China Med Mission. 1905, 19: 167-173. Boone H: Malta fever in China. China Med Mission. 1905, 19: 167-173.
17.
go back to reference Shang D: [Progress in the study of prevention and control of Brucellosis in China in last 50 years]. Zhonghua liu xing bing xue za zhi =Zhonghua liuxingbingxue zazhi. 2000, 21 (1): 55-57.PubMed Shang D: [Progress in the study of prevention and control of Brucellosis in China in last 50 years]. Zhonghua liu xing bing xue za zhi =Zhonghua liuxingbingxue zazhi. 2000, 21 (1): 55-57.PubMed
18.
go back to reference Cui YL: [Current status and prospect of brucellosis research in China]. Zhonghua liu xing bing xue za zhi =Zhonghua liuxingbingxue zazhi. 1983, 4 (3): 190-191.PubMed Cui YL: [Current status and prospect of brucellosis research in China]. Zhonghua liu xing bing xue za zhi =Zhonghua liuxingbingxue zazhi. 1983, 4 (3): 190-191.PubMed
19.
go back to reference Kattar MM, Jaafar RF, Araj GF, Le Fleche P, Matar GM, Abi Rached R, Khalife S, Vergnaud G: Evaluation of a multilocus variable-number tandem-repeat analysis scheme for typing human Brucella isolates in a region of brucellosis endemicity. J Clin Microbiol. 2008, 46 (12): 3935-3940. 10.1128/JCM.00464-08.CrossRefPubMedPubMedCentral Kattar MM, Jaafar RF, Araj GF, Le Fleche P, Matar GM, Abi Rached R, Khalife S, Vergnaud G: Evaluation of a multilocus variable-number tandem-repeat analysis scheme for typing human Brucella isolates in a region of brucellosis endemicity. J Clin Microbiol. 2008, 46 (12): 3935-3940. 10.1128/JCM.00464-08.CrossRefPubMedPubMedCentral
Metadata
Title
Changes of predominant species/biovars and sequence types of Brucellaisolates, Inner Mongolia, China
Authors
Yanfen Chen
Yuehua Ke
Yufei Wang
Xitong Yuan
Xiaoyan Zhou
Hai Jiang
Zhoujia Wang
Qing Zhen
Yaqin Yu
Liuyu Huang
Buyun Cui
Zeliang Chen
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-514

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine